Planatome Signs Multiphase Agreement With Major U.S. Supplier of Robotic-Assisted and Minimally Invasive Surgical Tools
Key Highlights
- ➤Planatome begins nano-polishing devices for an undisclosed major U.S. RAS/MIS supplier
- ➤Full technology integration into the supplier’s manufacturing line is scheduled for 2027
- ➤Global robotic-assisted surgery market forecast to grow 15% annually to over $45 billion by 2033
- ➤Amtech Systems (ASYS) acquired Planatome’s parent Entrepix in 2023
Expert Statements
Tim Tobin, Chief Executive Officer of Planatome
“This is exactly the kind of relationship we envisioned”
Tim Tobin, Chief Executive Officer of Planatome
“We’ve shown what this technology can do, infusing a level of value into surgical tooling that wasn’t possible before nano-polishing made the jump from semiconductor to medical.”
Tim Tobin, Chief Executive Officer of Planatome
“Today’s agreement is a foundational step as we move forward on a defined path to a much deeper commercial integration.”
Tim Tobin, Chief Executive Officer of Planatome
“Our nano-polishing platform applies across every core submarket of surgical cutting instruments: RAS/MIS, traditional open and orthopedic tooling among them. We’re actively expanding our commercial footprint with major players in each.”
Keith Jeffcoat, DEng, President and Chief Innovation Officer of Planatome
“Our patented nano-polishing technology was engineered to improve precision, durability of the blade edge, and consistency of the cutting surface that is critically important for high-value surgical devices”
Keith Jeffcoat, DEng, President and Chief Innovation Officer of Planatome
“This agreement extends our proven platform technology to commercial scale, bringing one of the most advanced cutting technologies into the medical device space.”
Matt Likens, Planatome board advisor and former CEO of GT Medical Technologies Inc. and Ulthera Inc.
“Having been involved in medtech and biosciences for decades, I’ve rarely seen an innovation that can significantly improve an entire class of products, in this case, all surgical cutting instruments,”
Matt Likens, Planatome board advisor and former CEO of GT Medical Technologies Inc. and Ulthera Inc.
“This agreement puts Planatome’s technology squarely inside one of medtech’s next great competitive battlegrounds, where new entrants are intensifying the race for a foothold.”
Matt Likens, Planatome board advisor and former CEO of GT Medical Technologies Inc. and Ulthera Inc.
“Competitors that act aggressively and decisively will benefit both clinically and financially by adopting this highly differentiated technology.”
Planatome Signs Multiphase Agreement With Major U.S. Supplier of Robotic-Assisted and Minimally Invasive Surgical Tools
Agreement deploys patented nano-polishing technology inside one of medtech's fastest-growing markets
Get started
Create a free account to read the full story.